Abiopharma

Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA® (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection

New Form EFFECT - AETHLON MEDICAL INC Filed: 2026-01-16 AccNo: 9999999995-26-000202 Size: 1 KB

New Form EFFECT - CollPlant Biotechnologies Ltd Filed: 2026-01-16 AccNo: 9999999995-26-000206 Size: 2 KB

New Form EFFECT - Tharimmune, Inc. Filed: 2026-01-16 AccNo: 9999999995-26-000208 Size: 1 KB

New Form EFFECT - SCWorx Corp. Filed: 2026-01-16 AccNo: 9999999995-26-000204 Size: 1 KB

New Form EFFECT - ALLURION TECHNOLOGIES, INC. Filed: 2026-01-16 AccNo: 9999999995-26-000210 Size: 1 KB

Natera - Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting

Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results

General Announcement: Press Release - iX Biopharma Named Among Singapores Fastest Growing Companies 2026

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

General Announcement: CHANGES IN DIRECTORS INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016

Semler Scientific Inc (SMLR) was removed from the list of traded instruments on NASDAQ exchange

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Semler Scientific, Inc. - Common Stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Semler Scientific, Inc. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: Semler Scientific, Inc. - Common Stock. New value: Semler Scientific, Inc. - Common Stock.